← Back to Search

Behavioral Intervention

Peer Support for Type 2 Diabetes (OASIS Trial)

N/A

Recruiting

Led By Brittany L Smalls, PhD

Research Sponsored by Brittany L Smalls

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Positive diagnosis of Type 2 Diabetes Mellitus

Age greater than or equal to 55 years

Must not have

Cognitive Impairment

Age less than 55 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up collected at baseline, 3 month, and 6 month follow up.

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at how peer coaching models can help older adults with Type 2 Diabetes better manage their condition.

Who is the study for?

This trial is for English-speaking adults over 55 living in rural Kentucky with Type 2 Diabetes. Peer coaches must have an HbA1c level below 7.5, while peer participants need a level above 7.5 and pass a cognitive assessment.

What is being tested?

The study tests different peer coaching methods to help manage Type 2 Diabetes in older adults. It looks at how often coaches contact patients, what they discuss, and how well the pairs are matched to see which approach works best.

What are the potential side effects?

Since this trial involves peer coaching rather than medication or medical procedures, there aren't typical side effects; however, participants may experience varying levels of stress or emotional impact from regular discussions about their health management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Type 2 Diabetes.

Select...

I am 55 years old or older.

Select...

I passed a cognitive test given by the study team.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have difficulty with memory or thinking clearly.

Select...

I am under 55 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected at baseline, 3 month, and 6 month follow up.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected at baseline, 3 month, and 6 month follow up.

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at baseline, 3 month, and 6 month follow up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of Participants with Change in A1c

Secondary study objectives

Acts of Daily Living

Depression Scale

Diabetes Empowerment

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Group I: Peer Participants (C)Experimental Treatment1 Intervention

Peer participants in group C will be matched with a peer coach by study personnel, and will be contacted weekly during intervention period.

Group II: Peer Participants (B)Experimental Treatment1 Intervention

Peer participants in group B will self select a peer coach using peer coach profile sheets, and will be contacted biweekly during intervention period.

Group III: Peer Participants (A)Experimental Treatment1 Intervention

Peer participants in group A will self select a peer coach using peer coach profile sheets, and will be contacted weekly during intervention period.

Group IV: Peer Participant (D)Experimental Treatment1 Intervention

Peer participants in group D will be matched with a peer coach by study personnel, and will be contacted biweekly during intervention period.

0 / 5Eligibility criteria met